Targeting matrix remodeling in cardiac hypertrophy and heart failure

Merry L. Lindsey, Francis G. Spinale

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Chronic pressure overload, such as that with hypertension, induces left ventricular (LV) remodeling characterized by increased mass, that is, LV hypertrophy (LVH). LVH can cause impaired diastolic function and thereby contribute to heart failure. The myocardial extracellular matrix undergoes significant remodeling in LVH contributing to abnormalities in diastolic function. Current pharmacological strategies for the treatment of hypertension only indirectly and/or incompletely affect the structure and composition of the myocardial matrix. Identifying crucial pathways involved in matrix remodeling in hypertension-induced LVH will aid in the selection of more relevant targets.

Original languageEnglish (US)
Pages (from-to)253-258
Number of pages6
JournalDrug Discovery Today: Therapeutic Strategies
Volume2
Issue number3
DOIs
StatePublished - Jan 1 2005

Fingerprint

Cardiomegaly
Hypertrophy
Heart Failure
Hypertension
Ventricular Remodeling
Left Ventricular Hypertrophy
Extracellular Matrix
Pharmacology
Pressure

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Cite this

Targeting matrix remodeling in cardiac hypertrophy and heart failure. / Lindsey, Merry L.; Spinale, Francis G.

In: Drug Discovery Today: Therapeutic Strategies, Vol. 2, No. 3, 01.01.2005, p. 253-258.

Research output: Contribution to journalReview article

@article{765ace46bbcb42ce8b9d1ca10880bfa1,
title = "Targeting matrix remodeling in cardiac hypertrophy and heart failure",
abstract = "Chronic pressure overload, such as that with hypertension, induces left ventricular (LV) remodeling characterized by increased mass, that is, LV hypertrophy (LVH). LVH can cause impaired diastolic function and thereby contribute to heart failure. The myocardial extracellular matrix undergoes significant remodeling in LVH contributing to abnormalities in diastolic function. Current pharmacological strategies for the treatment of hypertension only indirectly and/or incompletely affect the structure and composition of the myocardial matrix. Identifying crucial pathways involved in matrix remodeling in hypertension-induced LVH will aid in the selection of more relevant targets.",
author = "Lindsey, {Merry L.} and Spinale, {Francis G.}",
year = "2005",
month = "1",
day = "1",
doi = "10.1016/j.ddstr.2005.08.001",
language = "English (US)",
volume = "2",
pages = "253--258",
journal = "Drug Discovery Today: Therapeutic Strategies",
issn = "1740-6773",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Targeting matrix remodeling in cardiac hypertrophy and heart failure

AU - Lindsey, Merry L.

AU - Spinale, Francis G.

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Chronic pressure overload, such as that with hypertension, induces left ventricular (LV) remodeling characterized by increased mass, that is, LV hypertrophy (LVH). LVH can cause impaired diastolic function and thereby contribute to heart failure. The myocardial extracellular matrix undergoes significant remodeling in LVH contributing to abnormalities in diastolic function. Current pharmacological strategies for the treatment of hypertension only indirectly and/or incompletely affect the structure and composition of the myocardial matrix. Identifying crucial pathways involved in matrix remodeling in hypertension-induced LVH will aid in the selection of more relevant targets.

AB - Chronic pressure overload, such as that with hypertension, induces left ventricular (LV) remodeling characterized by increased mass, that is, LV hypertrophy (LVH). LVH can cause impaired diastolic function and thereby contribute to heart failure. The myocardial extracellular matrix undergoes significant remodeling in LVH contributing to abnormalities in diastolic function. Current pharmacological strategies for the treatment of hypertension only indirectly and/or incompletely affect the structure and composition of the myocardial matrix. Identifying crucial pathways involved in matrix remodeling in hypertension-induced LVH will aid in the selection of more relevant targets.

UR - http://www.scopus.com/inward/record.url?scp=27144441381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27144441381&partnerID=8YFLogxK

U2 - 10.1016/j.ddstr.2005.08.001

DO - 10.1016/j.ddstr.2005.08.001

M3 - Review article

AN - SCOPUS:27144441381

VL - 2

SP - 253

EP - 258

JO - Drug Discovery Today: Therapeutic Strategies

JF - Drug Discovery Today: Therapeutic Strategies

SN - 1740-6773

IS - 3

ER -